Red blood cell transfusion in preterm infants: current evidence and controversies
C Howarth, J Banerjee, N Aladangady - Neonatology, 2018 - karger.com
The current evidence regarding the indication, advantages and risks of red blood cell
transfusion (RBCT) for preterm infants is discussed. This is an important area in …
transfusion (RBCT) for preterm infants is discussed. This is an important area in …
[HTML][HTML] Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2021 - thelancet.com
Background In this study, we aimed to evaluate the effects of tocilizumab in adult patients
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
admitted to hospital with COVID-19 with both hypoxia and systemic inflammation. Methods …
Pregnancy and neonatal outcomes of COVID‐19: coreporting of common outcomes from PAN‐COVID and AAP‐SONPM registries
Objective Few large cohort studies have reported data on maternal, fetal, perinatal and
neonatal outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS …
neonatal outcomes associated with severe acute respiratory syndrome coronavirus 2 (SARS …
Infants' blood volume in a controlled trial of placental transfusion at preterm delivery
N Aladangady, S McHugh, TC Aitchison… - …, 2006 - publications.aap.org
OBJECTIVE. To investigate whether it was possible to promote placental blood transfer to
infants at preterm delivery by (1) delaying cord clamping,(2) holding the infant below the …
infants at preterm delivery by (1) delaying cord clamping,(2) holding the infant below the …
[HTML][HTML] Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2021 - thelancet.com
Background Many patients with COVID-19 have been treated with plasma containing anti-
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …
SARS-CoV-2 antibodies. We aimed to evaluate the safety and efficacy of convalescent …
[HTML][HTML] Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2022 - thelancet.com
Background Casirivimab and imdevimab are non-competing monoclonal antibodies that
bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike …
bind to two different sites on the receptor binding domain of the SARS-CoV-2 spike …
[HTML][HTML] Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
E Abaleke, M Abbas, S Abbasi, A Abbott, A Abdelaziz… - The Lancet, 2021 - thelancet.com
Background Azithromycin has been proposed as a treatment for COVID-19 on the basis of
its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin …
its immunomodulatory actions. We aimed to evaluate the safety and efficacy of azithromycin …
Biomarkers to decide red blood cell transfusion in newborn infants
J Banerjee, N Aladangady - Transfusion, 2014 - Wiley Online Library
Almost 90% of extremely low birthweight infants receive red blood cell (RBC) transfusion
during their stay in the neonatal unit (NNU). Currently most NNU s use a combination of …
during their stay in the neonatal unit (NNU). Currently most NNU s use a combination of …
[HTML][HTML] Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
O Abani, A Abbas, F Abbas, M Abbas, S Abbasi… - The Lancet, 2022 - thelancet.com
Background Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients …
[HTML][HTML] Pregnancy and neonatal outcomes of COVID-19: The PAN-COVID study
Objective To assess perinatal outcomes for pregnancies affected by suspected or confirmed
SARS-CoV-2 infection. Methods Prospective, web-based registry. Pregnant women were …
SARS-CoV-2 infection. Methods Prospective, web-based registry. Pregnant women were …